1. Phase III study of CCNU/VP-16/MTX/PREDNISONE for refractory CLL and malignant lymphoma, abstracted;Keller;Proc ASCO,1984
2. Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate;Tseng;Cancer Treat Rep,1987
3. Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project;National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas:;Cancer,1982
4. [Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas];Domingo-Albos;Sangre,1989
5. Hodgkin's disease;Vincent;Med J Aust,1989